Puretech Health plc (PRTC) Ordinary 1p
- Add to watchlist
- Create an alert
- This stock can be held in a
160.00p
171.20p
238.50p
£409.89 million
162.00p
160.00p
139.00p
n/a
0.20p (0.12%) Previous:
0.20p
519,048
n/a
2,000
Performance
1 week 1W | 0.23% | 1 year 1Y | 4.14% |
---|---|---|---|
1 month 1M | 9.6% | 2 years 2Y | 35.15% |
3 months 3M | 3.51% | 3 years 3Y | 47.16% |
6 months 6M | 24.42% | 5 years 5Y | 39.51% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
Year ending: | 31/12/2023 | 31/12/2022 |
---|---|---|
Revenue ($m) | 3.33 | 15.62 |
Profit before tax ($m) | (36.10) | (92.78) |
Adjusted EPS (¢): | (24.00) | (18.00) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: US dollar
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
London close: Stocks give up gains to finish in the red
21 October 2024 15:48
-
PureTech's Seaport closes $225m series B round
21 October 2024 12:45
-
London close: Stocks rise as US PCE inflation slows
27 September 2024 16:58
-
PRTC's Seaport Adds Microsoft and J&J Exec to BOD
20 November 2024 12:05
-
Total Voting Rights
1 November 2024 07:00
-
Director/PDMR Shareholding
31 October 2024 17:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.